Tumor heterogeneity: causes and consequences.

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  A. Haddow.  Cellular inhibition and the origin of cancer, with special reference to the mode of action of the carcinogenic hydrocarbons , 1937 .

[3]  R. Weinberg,et al.  The Biology of Cancer , 2006 .

[4]  S. Goldhor.  Ecology , 1964, The Yale Journal of Biology and Medicine.

[5]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[6]  K. Illmensee,et al.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[8]  R. Weinberg,et al.  Structure of the intermediates leading to the integrated provirus. , 1977, Biochimica et biophysica acta.

[9]  M. Kimura,et al.  The neutral theory of molecular evolution. , 1983, Scientific American.

[10]  P. Fialkow,et al.  Clonal origin of human tumors. , 1979, Annual review of medicine.

[11]  I. Fidler,et al.  Biological diversity in metastatic neoplasms: origins and implications. , 1982, Science.

[12]  G. Heppner.  Tumor heterogeneity. , 1984, Cancer research.

[13]  W. Hamilton,et al.  The Evolution of Cooperation , 1984 .

[14]  M. Weiss.  Biological Anthropology: The Neutral Theory of Molecular Evolution. Motoo Kimura , 1985 .

[15]  G. Schlimok,et al.  Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  F. Miller,et al.  Analysis of tumour cell composition in tumours composed of paired mixtures of mammary tumour cell lines. , 1987, British Journal of Cancer.

[17]  J. Leith,et al.  Growth properties of artificial heterogeneous human colon tumors. , 1987, Cancer research.

[18]  O. Kallioniemi.  Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. , 1988, Cytometry.

[19]  F. Miller,et al.  Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors. , 1988, Cancer research.

[20]  M. Kimura.  [Recent developments of the neutral theory of molecular evolution, and a world view based on the neutral theory]. , 1989, Idengaku zasshi.

[21]  G. Heppner,et al.  Cancer cell societies and tumor progression , 1993, Stem cells.

[22]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[23]  K. Hess,et al.  Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[25]  T. Wheeler,et al.  Heterogeneity of prostate cancer in radical prostatectomy specimens. , 1994, Urology.

[26]  R. Lenski,et al.  Evidence for multiple adaptive peaks from populations of bacteria evolving in a structured habitat. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Izbicki,et al.  Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  T C Gasser,et al.  Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. , 1995, Cytometry.

[29]  S. Coons,et al.  Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. , 1995, Cancer research.

[30]  N. Konishi,et al.  Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. , 1995, The American journal of pathology.

[31]  B. Johansson,et al.  Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups , 1995, Genes, chromosomes & cancer.

[32]  Lars Holmgren,et al.  Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.

[33]  F. Mitelman,et al.  Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra—and extra—tumorous samples from 3 patients , 1995, International journal of cancer.

[34]  J. Andersen,et al.  Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. , 1996, Cancer research.

[35]  E Gabrielson,et al.  Genetic divergence in the clonal evolution of breast cancer. , 1996, Cancer research.

[36]  J. Califano,et al.  11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .

[37]  D J Ruiter,et al.  HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS , 1996, The Journal of pathology.

[38]  C. Janeway.  Immunobiology: The Immune System in Health and Disease , 1996 .

[39]  W. Bodmer,et al.  Polyclonal Origin of Colonic Adenomas in an XO/XY Patient with FAP , 1996, Science.

[40]  W. Giaretti,et al.  Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy. , 1996, The American journal of pathology.

[41]  A. Schäffer,et al.  Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. , 1997, Cancer research.

[42]  I. Tomlinson,et al.  Game-theory models of interactions between tumour cells. , 1997, European journal of cancer.

[43]  W. F. Bodmer,et al.  Modelling the consequences of interactions between tumour cells. , 1997, British Journal of Cancer.

[44]  Michael Travisano,et al.  Adaptive radiation in a heterogeneous environment , 1998, Nature.

[45]  N. Maitland,et al.  Precise microdissection of human prostate cancers reveals genotypic heterogeneity. , 1998, Cancer research.

[46]  R. Hanada,et al.  Spontaneous regression of localized neuroblastoma detected by mass screening. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  M. Speicher,et al.  Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Schäffer,et al.  Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. , 1999, The American journal of pathology.

[49]  D. Bostwick,et al.  Allelic imbalance in the clonal evolution of prostate carcinoma , 1999, Cancer.

[50]  M. Slattery,et al.  Regional reproducibility of microsatellite instability in sporadic colorectal cancer , 1999, Genes, chromosomes & cancer.

[51]  M. Lensch,et al.  Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia , 1999, Leukemia.

[52]  R. Hruban,et al.  Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. , 2000, Cancer research.

[53]  P. Chesson.  Mechanisms of Maintenance of Species Diversity , 2000 .

[54]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[55]  M J Bissell,et al.  The influence of the microenvironment on the malignant phenotype. , 2000, Molecular medicine today.

[56]  Mel Greaves,et al.  Cancer: The Evolutionary Legacy , 2000 .

[57]  W. Falk,et al.  A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. , 2001, Cancer research.

[58]  E. Laconi,et al.  A growth-constrained environment drives tumor progression in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  B. Hero,et al.  Neuroblastoma , 2007, The Lancet.

[60]  I. Tomlinson,et al.  Loss of heterozygosity analysis: Practically and conceptually flawed? , 2002, Genes, chromosomes & cancer.

[61]  R. Solé,et al.  Metapopulation dynamics and spatial heterogeneity in cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  T. Czárán,et al.  Chemical warfare between microbes promotes biodiversity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Blagosklonny.  Oncogenic resistance to growth-limiting conditions , 2002, Nature Reviews Cancer.

[64]  U. Lehmann,et al.  Marked Intratumoral Heterogeneity of c-myc and CyclinD1 But Not of c-erbB2 Amplification in Breast Cancer , 2002, Laboratory Investigation.

[65]  J. Kuriyan,et al.  Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. , 2002, Cancer cell.

[66]  N. Stoecklein,et al.  Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer , 2002, The Lancet.

[67]  Claude Preudhomme,et al.  Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment. , 2002, Blood.

[68]  J. Köllermann,et al.  Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Ingo Roeder,et al.  A novel dynamic model of hematopoietic stem cell organization based on the concept of within-tissue plasticity. , 2002, Experimental hematology.

[70]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[71]  A. ADoefaa,et al.  ? ? ? ? f ? ? ? ? ? , 2003 .

[72]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[73]  Annuska M Glas,et al.  Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[74]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[75]  Armand M. Leroi,et al.  Cancer selection , 2003, Nature Reviews Cancer.

[76]  W. Thilly.  Have environmental mutagens caused oncomutations in people? , 2003, Nature Genetics.

[77]  A. Ashworth,et al.  Close relatives or distant cousins? , 2003, The Lancet. Oncology.

[78]  Robert A Gatenby,et al.  Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies. , 2003, Molecular cancer therapeutics.

[79]  R. Eils,et al.  From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[80]  W. Hofmann,et al.  Presence of the BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment in patients with Ph+ acute lymphoblastic leukemia. , 2003, Blood.

[81]  T. Vincent,et al.  An evolutionary model of carcinogenesis. , 2003, Cancer research.

[82]  Daniel Pinkel,et al.  Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH. , 2003, Genome research.

[83]  P. Amarasekare.  Competitive coexistence in spatially structured environments: a synthesis , 2003 .

[84]  N. Theise.  Perspective: stem cells react! Cell lineages as complex adaptive systems. , 2004, Experimental hematology.

[85]  G. Nicolson.  Generation of phenotypic diversity and progression in metastatic tumor cells , 2004, Cancer and Metastasis Reviews.

[86]  S. Leibler,et al.  Bacterial Persistence as a Phenotypic Switch , 2004, Science.

[87]  Mark J. Murphy,et al.  c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. , 2004, Genes & development.

[88]  J. Nagy.  Competition and natural selection in a mathematical model of cancer , 2004, Bulletin of mathematical biology.

[89]  M. König,et al.  Clonal variation of the immunogenotype in relapsed ETV6/RUNX1‐positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development , 2004, Genes, chromosomes & cancer.

[90]  P. Quesenberry,et al.  Differentiation hotspots: the deterioration of hierarchy and stochasm. , 2004, Blood cells, molecules & diseases.

[91]  M. Nowak,et al.  Dynamics of cancer progression , 2004, Nature Reviews Cancer.

[92]  M. Greaves,et al.  TEL Deletion Analysis Supports a Novel View of Relapse in Childhood Acute Lymphoblastic Leukemia , 2004, Clinical Cancer Research.

[93]  Stephanie Forrest,et al.  Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[94]  Carlos L Arteaga,et al.  Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them? , 2004, Cancer cell.

[95]  Ingo Roeder,et al.  Conceptual models to understand tissue stem cell organization , 2004, Current opinion in hematology.

[96]  S. Lowe,et al.  Intrinsic tumour suppression , 2004, Nature.

[97]  R. Gangnus,et al.  Genomic Profiling of Viable and Proliferative Micrometastatic Cells from Early-Stage Breast Cancer Patients , 2004, Clinical Cancer Research.

[98]  B. Druker,et al.  Oncogenes and Tumor Suppressors (795 articles) , 2004 .

[99]  O. Sieber,et al.  Tissue, cell and stage specificity of (epi)mutations in cancers , 2005, Nature Reviews Cancer.

[100]  N. Pandis,et al.  Cytogenetic manifestations of multiple myeloma heterogeneity , 2005, Genes, chromosomes & cancer.

[101]  Kyle Summers,et al.  Evolutionary biology of cancer. , 2005, Trends in ecology & evolution.

[102]  R. Cardiff,et al.  Impaired DNA Replication within Progenitor Cell Pools Promotes Leukemogenesis , 2005, PLoS biology.

[103]  Michael R. Green,et al.  A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake , 2005, Cell.

[104]  J. McGregor.  Context , 2018, J. Object Technol..

[105]  S. Hughes,et al.  Whole Genome Amplification , 2020, Definitions.

[106]  J. V. van Dongen,et al.  Immunogenotype Changes Prevail in Relapses of Young Children with TEL-AML1-Positive Acute Lymphoblastic Leukemia and Derive Mainly from Clonal Selection , 2005, Clinical Cancer Research.

[107]  Mina J Bissell,et al.  Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? , 2005, Cancer cell.

[108]  K. Sircar,et al.  Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer. , 2005, Cancer research.

[109]  C. Perou,et al.  Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. , 2005, Cancer research.

[110]  P. Chambon,et al.  Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[111]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[112]  Xi C. He,et al.  PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention , 2006, Nature.

[113]  K. Pienta,et al.  Evolution of cooperation among tumor cells , 2006, Proceedings of the National Academy of Sciences.

[114]  Carissa A. Sanchez,et al.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.

[115]  R. Hill.  Identifying cancer stem cells in solid tumors: case not proven. , 2006, Cancer research.

[116]  J. Andersen,et al.  Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases , 2007, Breast Cancer Research and Treatment.

[117]  A. Piotrowski,et al.  Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity. , 2006, International Journal of Oncology.

[118]  C. Klein,et al.  Systemic Cancer Progression and Tumor Dormancy: Mathematical Models Meet Single Cell Genomics , 2006, Cell cycle.

[119]  K. Coombes,et al.  Zonal heterogeneity for gene expression in human pancreatic carcinoma. , 2007, Cancer research.

[120]  S. Levin.  Evolutionary Dynamics: Exploring the Equations of Life.ByMartin A Nowak.Belknap Press. Cambridge (Massachusetts): Harvard University Press.$35.00. xiii + 363 p; ill.; index. ISBN: 0‐674‐02338‐2. 2006. , 2007 .

[121]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[122]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.

[123]  Mary R. Myerscough,et al.  Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions , 2007, Clinical & Experimental Metastasis.

[124]  Aleksandar Dakic,et al.  Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.

[125]  T. Conroy,et al.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[126]  S. Kern,et al.  The fuzzy math of solid tumor stem cells: a perspective. , 2007, Cancer research.

[127]  K Fenwick,et al.  Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy , 2006, British Journal of Cancer.

[128]  V. Gadi,et al.  Fetal microchimerism in women with breast cancer. , 2007, Cancer research.

[129]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[130]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[131]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[132]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[133]  E. Sahai,et al.  Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement , 2008, Cell.

[134]  F. Couch,et al.  Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers , 2008, Nature.

[135]  Y. Refaeli,et al.  B-cell receptor signaling in the genesis and maintenance of B-cell lymphoma. , 2008, Future oncology.

[136]  A. Ullrich,et al.  Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. , 2008, Cancer cell.

[137]  J. Dick,et al.  Stem cell concepts renew cancer research. , 2008, Blood.

[138]  Kevin Gross,et al.  Positive interactions among competitors can produce species-rich communities. , 2008, Ecology letters.

[139]  M. Stratton,et al.  Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing , 2008, Proceedings of the National Academy of Sciences.

[140]  Robert Axelrod,et al.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. , 2008, Translational oncology.

[141]  A. Marusyk,et al.  Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. , 2008, Biochimica et biophysica acta.

[142]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[143]  James R. Downing,et al.  Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia , 2008, Science.

[144]  M. Heinrich,et al.  Molecular pathobiology of gastrointestinal stromal sarcomas. , 2008, Annual review of pathology.

[145]  Jorge S. Reis-Filho,et al.  Resistance to therapy caused by intragenic deletion in BRCA2 , 2008, Nature.

[146]  Harold Varmus,et al.  Seeding and Propagation of Untransformed Mouse Mammary Cells in the Lung , 2008, Science.

[147]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[148]  P. Vineis,et al.  The microenvironments of multistage carcinogenesis. , 2008, Seminars in cancer biology.

[149]  R. Weinberg,et al.  Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.

[150]  J. Klawitter,et al.  Irradiation alters selection for oncogenic mutations in hematopoietic progenitors. , 2009, Cancer research.

[151]  G. Parmigiani,et al.  Design and analysis issues in genome-wide somatic mutation studies of cancer. , 2009, Genomics.

[152]  S. Devries,et al.  Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma , 2009, Modern Pathology.

[153]  Ryan D. Morin,et al.  Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.

[154]  N. Balaban,et al.  The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. , 2009, FEMS microbiology reviews.

[155]  D. Wilson.  Tissue , 2009, The Lancet.

[156]  B. Frieden,et al.  Adaptive therapy. , 2009, Cancer research.

[157]  Jun Luo,et al.  Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer , 2009, Nature Medicine.

[158]  Izhak Haviv,et al.  Co-evolution of tumor cells and their microenvironment. , 2009, Trends in genetics : TIG.

[159]  Paul Marjoram,et al.  Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers , 2009, Proceedings of the National Academy of Sciences.

[160]  P. Sorger,et al.  Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.

[161]  M. Gönen,et al.  Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.